Entering Phase I
Published 09/2007 by admin@immutep.com
© 2002 Immutep, S.A.
|
Entering Phase IPublished 09/2007 by admin@immutep.com © 2002 Immutep, S.A.
|
Press Release
06/2008 - LAG-3 Enhances Activity of a Cellular Cancer Immunotherapy
11/2007 - IMP321 first results in metastatic breast cancer 09/2007 - IMP321’s potency as a new immunopotentiator in cancer patients 09/2007 - Entering Phase I 10/2006 - Entering Phase I |
||||||||||||||||